数字农科院2.0

Immune Responses In Mice And Pigs After Oral Vaccination With Rabies Virus Vectored Nipah Disease Vaccines

文献类型： 外文期刊

作者： Shuai, L; Ge, JY; Wen, ZY; Wang, JL; Wang, XJ; Bu, ZG

作者机构：

关键词： Rabies Virus; Nipah Virus; Attachment Glycoprotein; Fusion Glycoprotein; Oral Vaccine

期刊名称： VETERINARY MICROBIOLOGY

ISSN： 0378-1135

年卷期： 2020 年 241 卷

页码：

收录情况： JCR（2021版）

摘要： Nipah virus (NiV) is a re-emerging zoonotic pathogen that causes high mortality in humans and pigs. Oral immunization in free-roaming animals is one of the most practical approaches to prevent NiV pandemics. We previously generated a recombinant rabies viruses (RABV) Evelyn-Rokitnicki-Abelseth (ERA) strain, rERAG(333E), which contains a mutation from arginine to glutamic acid at residue 333 of glycoprotein (G(333E)) and serves as an oral vaccine for dog rabies. In this study, we generated two recombinant RABVs, rERAG(333E)/NiVG and rERAG(333E)/NiVF, expressing the NiV Malaysian strain attachment glycoprotein (NiV-G) or fusion glycoprotein (NiV-F) gene based on the rERAG 333E vector platform. Both rERAG(333E)/NiVG and rERAG(333E)/NiVF displayed growth properties similar to those of rERAG(333E) and caused marked syncytia formation after co-infection in BSR cell culture. Adult and suckling mice intracerebrally inoculated with the recombinant RABVs showed NiV-G and NW-F expression did not increase the virulence of rERAG(333E). Oral vaccination with rERAG(333E)/NiVG either singularly or combined with rERAG(333E)/NiVF induced significant NiV neutralizing antibody against NiV and RABV, and IgG to NiV-G or NiV-F in mice and pigs. rERAG(333E)/NiVG and rERAG(333E)/NiVF thus appeared to be suitable candidates for further oral vaccines for potential animal targets in endemic areas of NiV disease and rabies.

分类号：

  • 相关文献

[1]Genetically Modified Rabies Virus-Vectored Ebola V.irus Disease Vaccines Are S afe And Induce Efficacious Immune Responses In Mice And Dogs. Wen, Zhiyuan,Wang, Xijun,Bu, Zhigao,Zhao, Dandan,Ge, Jinying,Shuai, Lei,Wang, Jinliang. 2017

[2]Oral Vaccination With The Porcine C.ircovirus Type 2 (Pcv-2) C apsid Protein Expressed By Lactococcus Lactis Induces A Specific Immune Response Against Pcv-2 In Mice. Wang, L, Zhao, D, Sun, B, Yu, M, Wang, Y, Ru, Y, Jiang, Y, Qiao, X, Cui, W, Zhou, H, Li, Y, Xu, Y, Tang, L. 2019

[3]Replication-competent vaccinia virus-vectored oral vaccines provide complete protection against the SARS-CoV-2 challenge and effectively prevent viral transmission via respiratory droplets in mice and minks. Linya Feng, Hong Huo, Yunlei Wang, Lei Shuai, Gongxun Zhong, Zhiyuan Wen, Liyan Peng, Jinying Ge, Jinliang Wang, Chong Wang, Weiye Chen, Xijun He, Xijun Wang, Zhigao Bu. 2025

[4]Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies. Niu, Yange,Yang, Limin,Qu, Hongren,Li, Jing,Liu, Wenjun,Niu, Yange,Liu, Wenjun,Liu, Ye,Hu, Rongliang,Liu, Ye,Hu, Rongliang,Zhao, Jingyi,Li, Jing. 2016

[5]Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice. Huang, Chien-Tsun,Li, Zhenguang,Huang, Ying,Zhang, Guoqing,Zhou, Ming,Chai, Qingqing,Fu, Zhen F.,Li, Zhenguang,Wu, Hua,Fu, Zhen F..

[6]Characterization of a virulent dog-originated rabies virus affecting more than twenty fallow deer (Dama dama) in Inner Mongolia, China. Zhu, Hongwei,Shao, Xiqun,Ba, Hengxing,Wang, Fengxue,Yang, Yong,Sun, Na,Ren, Jingqiang,Cheng, Shipeng,Wen, Yongjun,Chen, Xiaoyun,Wang, Hualei.

[7]Engineering, expression, and immuno-characterization of recombinant protein comprising multi-neutralization sites of rabies virus glycoprotein. Li, Xiangdong,Luo, Jinyan,Shen, Yang,Qiu, Yafeng,Wang, Xiaodu,Deng, Xufang,Ding, Chan,Ma, Zhiyong,Wang, Shuiming,Liu, Xuehui,Bao, Weidong,Liu, Peihong,Zhou, Jinping.

[8]Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice. Xiao, Xing-xing,Zhang, Yun,Liu, Ji-xing,Wei, Qiao-lin,Yin, Xiang-ping.

[9]An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice. Xue, Xiang-Hong,Li, Ling,Yang, Song-Tao,Xia, Xian-Zhu,Xue, Xiang-Hong,Zheng, Xue-Xing,Wang, Hua-Lei,Ma, Jin-Zhu,Li, Ling,Gai, Wei-Wei,Wang, Tie-Cheng,Yang, Song-Tao,Xia, Xian-Zhu,Zheng, Xue-Xing,Ma, Jin-Zhu.

[10]Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge. Wang, Feng-Xue,Zhang, Shu-Qin,Zhu, Hong-Wei,Yang, Yong,Sun, Na,Tan, Bin,Li, Zhen-Guang,Cheng, Shi-Peng,Wen, Yong-Jun,Li, Zhen-Guang,Fu, Zhen F..

[11]Generation Of Recombinant Rabies Virus E.ra Strain Applied To V irus Tracking In Cell Infection. Wen Zhi:yuan,Liu Ren:qiang,Wang Xi:jun,Ge Jin:ying,Bu Zhi:gao,Shuai Lei,Bu Zhi:gao,Wang Jin:liang,Wang Chong,Zhao Dan:dan. 2019

[12]Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Shuai, Lei,Wang, Xijun,Ge, Jinying,Wen, Zhiyuan,Chen, Weiye,Qin, Lide,Bu, Zhigao,Feng, Na,Xia, Xianzhu.

[13]Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens. Budaszewski, Renata da Fontoura,Budaszewski, Renata da Fontoura,Sawatsky, Bevan,Kraemer, Beate,von Messling, Veronika,Sawatsky, Bevan,von Messling, Veronika,Hudacek, Andrew,Yin, Xiangping,Schnell, Matthias J.,Yin, Xiangping.

[14]Molecular characterization of China rabies virus vaccine strain. Jiao, Wenqiang,Yin, Xiangping,Li, Zhiyong,Lan, Xi,Li, Xuerui,Tian, Xiaoting,Li, Baoyu,Yang, Bin,Zhang, Yun,Liu, Jixing. 2011

[15]Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs. Shuai, Lei,Wang, Xijun,Wen, Zhiyuan,Ge, Jinying,Wang, Jinliang,Zhao, Dandan,Bu, Zhigao.

[16]Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production. Tao, Lihong,Ge, Jinying,Wang, Xijun,Wen, Zhiyuan,Zhai, Hongyue,Hua, Tao,Zhao, Bolin,Kong, Dongni,Bu, Zhigao,Yang, Chinglai. 2011

[17]Rabies virus nucleoprotein expressed in silkworm pupae at high-levels and evaluation of immune responses in mice. Yin, Xiangping,Li, Zhiyong,Li, Jiangtao,Zhang, Yun,Li, Xuerui,Li, Baoyu,Yang, Bin,Lan, Xi,Jiao, Wenqiang,Liu, Jixing,Yi, Yongzhu,Li, Yinv,Zhang, Zhifang.

[18]Generation of Recombinant Rabies Virus CVS-11 Expressing eGFP Applied to the Rapid Virus Neutralization Test. Xue, Xianghong,Zheng, Xuexing,Liang, Hongru,Feng, Na,Zhao, Yongkun,Gao, Yuwei,Wang, Hualei,Yang, Songtao,Xia, Xianzhu,Xue, Xianghong,Yang, Songtao,Xia, Xianzhu,Zheng, Xuexing,Xia, Xianzhu. 2014

[19]Integrin Beta 1 Promotes Peripheral Entry By Rabies Virus. Shuai, L, Wang, JL, Zhao, DD, Wen, ZY, Ge, JY, He, XJ, Wang, XJ, Bu, ZG. 2020

[20]The ATPase ATP6V1A facilitates rabies virus replication by promoting virion uncoating and interacting with the viral matrix protein. Xing Liu1‡ , Fang Li1‡ , Jiwen Zhang1 , Lulu Wang1 , Jinliang Wang1 , Zhiyuan Wen1 , Zilong Wang1 , Lei Shuai1 , Xijun Wang1 , Jinying Ge1 , Dongming Zhao1,2*, Zhigao Bu1,2. 2020

作者其他论文 更多>>